Correlation Between ImmunoGen and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both ImmunoGen and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmunoGen and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmunoGen and Viking Therapeutics, you can compare the effects of market volatilities on ImmunoGen and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmunoGen with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmunoGen and Viking Therapeutics.
Diversification Opportunities for ImmunoGen and Viking Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between ImmunoGen and Viking is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoGen and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and ImmunoGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmunoGen are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of ImmunoGen i.e., ImmunoGen and Viking Therapeutics go up and down completely randomly.
Pair Corralation between ImmunoGen and Viking Therapeutics
If you would invest 1,820 in ImmunoGen on September 4, 2024 and sell it today you would earn a total of 0.00 from holding ImmunoGen or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
ImmunoGen vs. Viking Therapeutics
Performance |
Timeline |
ImmunoGen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Viking Therapeutics |
ImmunoGen and Viking Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ImmunoGen and Viking Therapeutics
The main advantage of trading using opposite ImmunoGen and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmunoGen position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.ImmunoGen vs. Madrigal Pharmaceuticals | ImmunoGen vs. TG Therapeutics | ImmunoGen vs. Terns Pharmaceuticals | ImmunoGen vs. Hepion Pharmaceuticals |
Viking Therapeutics vs. Candel Therapeutics | Viking Therapeutics vs. Cingulate Warrants | Viking Therapeutics vs. Unicycive Therapeutics | Viking Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |